Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

2 terminated/withdrawn out of 141 trials

Success Rate

97.1%

+10.6% vs industry average

Late-Stage Pipeline

9%

12 trials in Phase 3/4

Results Transparency

3%

2 of 67 completed trials have results

Key Signals

30 recruiting2 with results

Enrollment Performance

Analytics

N/A
59(72.0%)
Phase 3
8(9.8%)
Phase 2
8(9.8%)
Phase 4
4(4.9%)
Early Phase 1
2(2.4%)
Phase 1
1(1.2%)
82Total
N/A(59)
Phase 3(8)
Phase 2(8)
Phase 4(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (141)

Showing 20 of 141 trials
NCT05750706Completed

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Role: collaborator

NCT06652776Enrolling By Invitation

The Italian Registry of Patients With Chronic Obstructive Pulmonary Disease

Role: collaborator

NCT07502807Not ApplicableNot Yet Recruiting

Effect of Neurofast® Supplementation on Anxiety and Cardiovascular Outcomes in the Psycho-Cardio Phenotype Adults

Role: collaborator

NCT07494279Not ApplicableNot Yet Recruiting

Efficacy of Nigella Sativa (Nisatol®) in Women With Borderline Blood Pressure Values or a Non-Dipper Blood Pressure Phenotype

Role: collaborator

NCT07448727Recruiting

Impact of Early Response to First-line Anti-PD-1 Monotherapy in Patients With Recurrent and/or Metastatic (R/M) Head and Neck Squamous Cell Carcinoma, Assessed by 18F-FDG PET/CT

Role: lead

NCT07413419Not ApplicableNot Yet Recruiting

Evaluation of Remote Motivational Interviewing for Disease Management in Heart Failure Patients and Their Carers

Role: collaborator

NCT07390903Recruiting

GLS in Difficult CPB Weaning

Role: collaborator

NCT07313358Not Yet Recruiting

10119473 -VIROMARKERS HDV Biomarkers Study

Role: lead

NCT06504485Recruiting

Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide Treatment

Role: collaborator

NCT07316894Recruiting

IWS Diagnosis Criteria Consensus

Role: collaborator

NCT07286461Not Yet Recruiting

VIROMARKERS GA n.101194735 - CMV and TTV Biomarkers Study Protocol

Role: lead

NCT03553420Recruiting

Registry for Patients With Lipodystrophy

Role: collaborator

NCT05531773Recruiting

Post COVID-19 Condition

Role: collaborator

NCT07103122Not ApplicableActive Not Recruiting

Virtual Reality Therapy for Arm Recovery (VVITA) Stroke

Role: collaborator

NCT06130046Recruiting

MR-proADM as a Early Biomarker for DGF and AR in Kidney and Liver Transplantation

Role: lead

NCT07067749Phase 3Recruiting

Treatment Expedition With MRI Processing and Optimization for Muscle Invasive Bladder Cancer

Role: lead

NCT05071105Not ApplicableRecruiting

SBRT in Early Breast Cancer in Elderly Women

Role: lead

NCT06959979Early Phase 1Recruiting

Novel Molecular Targets and Innovative Therapeutic Perspective in Medulloblastoma

Role: collaborator

NCT06514573Not ApplicableRecruiting

Butyrate Supplementation in Children With Autism Spectrum Disorder (ASD) and Functional Gastrointestinal Disorders

Role: collaborator

NCT06939621Not ApplicableCompleted

Trajectories for Active and Healthy Aging

Role: collaborator